Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine.

R. N. González, James S Cullor, D. E. Jasper, Thomas B Farver, R. B. Bushnell, M. N. Oliver

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

A prospective cohort study was undertaken in two commercial California dairies. The treatment group, 246 cows, received three doses of a whole cell bacterin of J5 Escherichia coli (mutant of E. coli O111:B4) plus Freund's incomplete adjuvant vaccine (two in the dry period and one after calving) while 240 unvaccinated cows served as controls. Thirty-five cases of clinical coliform mastitis were diagnosed, six in vaccinated cows and 29 in unvaccinated cows. Bacteria isolated from the clinical cases included 15 E. coli five Klebsiella pneumoniae, three K. oxytoca, three K. ozaenae, five Enterobacter aerogenes, three Serratia marcescens and one Serratia spp. Four control cows were culled, three of them because of chronic coliform mastitis and one because of postcoliform infection agalactia. Incidence rate of clinical gram-negative mastitis was 2.57% in vaccinated cows and 12.77% in unvaccinated cows. The estimated risk ratio, the measure of risk of having clinical gram-negative mastitis for vaccinated cows to unvaccinated cows, was 0.20 (p less than 0.005), indicating a strong relationship between vaccination and lack of clinical gram-negative mastitis. The results of this trial indicate that the administration of the E. coli J5 vaccine is protective against natural challenge to gram-negative bacteria, and reduces the incidence of clinical gram-negative mastitis in dairy cows during the first three months of lactation.

Original languageEnglish (US)
Pages (from-to)301-305
Number of pages5
JournalCanadian journal of veterinary research = Revue canadienne de recherche veterinaire
Volume53
Issue number3
StatePublished - Jul 1989

Fingerprint

Escherichia coli Vaccines
Mastitis
mastitis
dairy cows
vaccines
Escherichia coli
cows
mutants
Bacterial Vaccines
Enterobacter aerogenes
Serratia
Serratia marcescens
Incidence
Klebsiella pneumoniae
Gram-Negative Bacteria
Lactation
Klebsiella oxytoca
agalactia
incidence
vaccine adjuvants

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine. / González, R. N.; Cullor, James S; Jasper, D. E.; Farver, Thomas B; Bushnell, R. B.; Oliver, M. N.

In: Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, Vol. 53, No. 3, 07.1989, p. 301-305.

Research output: Contribution to journalArticle

@article{d7a91edc543047588898f85a277d9983,
title = "Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine.",
abstract = "A prospective cohort study was undertaken in two commercial California dairies. The treatment group, 246 cows, received three doses of a whole cell bacterin of J5 Escherichia coli (mutant of E. coli O111:B4) plus Freund's incomplete adjuvant vaccine (two in the dry period and one after calving) while 240 unvaccinated cows served as controls. Thirty-five cases of clinical coliform mastitis were diagnosed, six in vaccinated cows and 29 in unvaccinated cows. Bacteria isolated from the clinical cases included 15 E. coli five Klebsiella pneumoniae, three K. oxytoca, three K. ozaenae, five Enterobacter aerogenes, three Serratia marcescens and one Serratia spp. Four control cows were culled, three of them because of chronic coliform mastitis and one because of postcoliform infection agalactia. Incidence rate of clinical gram-negative mastitis was 2.57{\%} in vaccinated cows and 12.77{\%} in unvaccinated cows. The estimated risk ratio, the measure of risk of having clinical gram-negative mastitis for vaccinated cows to unvaccinated cows, was 0.20 (p less than 0.005), indicating a strong relationship between vaccination and lack of clinical gram-negative mastitis. The results of this trial indicate that the administration of the E. coli J5 vaccine is protective against natural challenge to gram-negative bacteria, and reduces the incidence of clinical gram-negative mastitis in dairy cows during the first three months of lactation.",
author = "Gonz{\'a}lez, {R. N.} and Cullor, {James S} and Jasper, {D. E.} and Farver, {Thomas B} and Bushnell, {R. B.} and Oliver, {M. N.}",
year = "1989",
month = "7",
language = "English (US)",
volume = "53",
pages = "301--305",
journal = "Canadian Journal of Veterinary Research",
issn = "0830-9000",
publisher = "Canadian Veterinary Medical Association",
number = "3",

}

TY - JOUR

T1 - Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine.

AU - González, R. N.

AU - Cullor, James S

AU - Jasper, D. E.

AU - Farver, Thomas B

AU - Bushnell, R. B.

AU - Oliver, M. N.

PY - 1989/7

Y1 - 1989/7

N2 - A prospective cohort study was undertaken in two commercial California dairies. The treatment group, 246 cows, received three doses of a whole cell bacterin of J5 Escherichia coli (mutant of E. coli O111:B4) plus Freund's incomplete adjuvant vaccine (two in the dry period and one after calving) while 240 unvaccinated cows served as controls. Thirty-five cases of clinical coliform mastitis were diagnosed, six in vaccinated cows and 29 in unvaccinated cows. Bacteria isolated from the clinical cases included 15 E. coli five Klebsiella pneumoniae, three K. oxytoca, three K. ozaenae, five Enterobacter aerogenes, three Serratia marcescens and one Serratia spp. Four control cows were culled, three of them because of chronic coliform mastitis and one because of postcoliform infection agalactia. Incidence rate of clinical gram-negative mastitis was 2.57% in vaccinated cows and 12.77% in unvaccinated cows. The estimated risk ratio, the measure of risk of having clinical gram-negative mastitis for vaccinated cows to unvaccinated cows, was 0.20 (p less than 0.005), indicating a strong relationship between vaccination and lack of clinical gram-negative mastitis. The results of this trial indicate that the administration of the E. coli J5 vaccine is protective against natural challenge to gram-negative bacteria, and reduces the incidence of clinical gram-negative mastitis in dairy cows during the first three months of lactation.

AB - A prospective cohort study was undertaken in two commercial California dairies. The treatment group, 246 cows, received three doses of a whole cell bacterin of J5 Escherichia coli (mutant of E. coli O111:B4) plus Freund's incomplete adjuvant vaccine (two in the dry period and one after calving) while 240 unvaccinated cows served as controls. Thirty-five cases of clinical coliform mastitis were diagnosed, six in vaccinated cows and 29 in unvaccinated cows. Bacteria isolated from the clinical cases included 15 E. coli five Klebsiella pneumoniae, three K. oxytoca, three K. ozaenae, five Enterobacter aerogenes, three Serratia marcescens and one Serratia spp. Four control cows were culled, three of them because of chronic coliform mastitis and one because of postcoliform infection agalactia. Incidence rate of clinical gram-negative mastitis was 2.57% in vaccinated cows and 12.77% in unvaccinated cows. The estimated risk ratio, the measure of risk of having clinical gram-negative mastitis for vaccinated cows to unvaccinated cows, was 0.20 (p less than 0.005), indicating a strong relationship between vaccination and lack of clinical gram-negative mastitis. The results of this trial indicate that the administration of the E. coli J5 vaccine is protective against natural challenge to gram-negative bacteria, and reduces the incidence of clinical gram-negative mastitis in dairy cows during the first three months of lactation.

UR - http://www.scopus.com/inward/record.url?scp=0024697510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024697510&partnerID=8YFLogxK

M3 - Article

C2 - 2670166

AN - SCOPUS:0024697510

VL - 53

SP - 301

EP - 305

JO - Canadian Journal of Veterinary Research

JF - Canadian Journal of Veterinary Research

SN - 0830-9000

IS - 3

ER -